<inglise> Commission Regulation (EC) No 2659/2000 of 29 November 2000 on the application of Article 81(3) of the Treaty to categories of research and development agreements (Text with EEA relevance) </inglise>
<eesti> KOMISJONI M&Auml;&Auml;RUS (EM&Uuml;) nr 2659/2000 asutamislepingu artikli 81 l&otilde;ike 3 kohaldamise kohta teadus- ja arenduskokkulepete liikide suhtes 29. november 2000 (EMPs kohaldatav tekst) </eesti>
<inglise> THE COMMISSION OF THE EUROPEAN COMMUNITIES, </inglise>
<eesti> EUROOPA &Uuml;HENDUSTE KOMISJON, </eesti>
<inglise> Having regard to the Treaty establishing the European Community, </inglise>
<eesti> v&otilde;ttes arvesse Euroopa &Uuml;henduse asutamislepingut, </eesti>
<inglise> Having regard to Council Regulation (EEC) No 2821/71 of 20 December 1971 on application of Article 85(3) of the Treaty to categories of agreements, decisions and concerted practices(1), as last amended by the Act of Accession of Austria, Finland and Sweden, and in particular Article 1(1) (b) thereof, </inglise>
<eesti> v&otilde;ttes arvesse n&otilde;ukogu 20. detsembri 1971. aasta m&auml;&auml;rust (EM&Uuml;) nr 2821/71 asutamislepingu artikli 85 l&otilde;ike 3 kohaldamise kohta teatavate kokkulepete, otsuste ja koosk&otilde;lastatud tegevuse suhtes, (1) viimati muudetud Austria, Soome ja Rootsi &uuml;hinemisaktiga, ning eriti selle artikli 1 l&otilde;ike 1 punkti b, </eesti>
<inglise> Having published a draft of this Regulation(2), </inglise>
<eesti> olles avaldanud k&auml;esoleva m&auml;&auml;ruse eeln&otilde;u, (2) </eesti>
<inglise> Having consulted the Advisory Committee on Restrictive Practices and Dominant Positions, </inglise>
<eesti> olles konsulteerinud konkurentsi piiravat tegevust ja turgu valitsevat seisundit k&auml;sitleva n&otilde;uandekomiteega </eesti>
<inglise> Whereas: </inglise>
<eesti> ning arvestades, et: </eesti>
<inglise> (1) Regulation (EEC) No 2821/71 empowers the Commission to apply Article 81(3) (formerly Article 85(3)) of the Treaty by regulation to certain categories of agreements, decisions and concerted practices falling within the scope of Article 81(1) which have as their object the research and development of products or processes up to the stage of industrial application, and exploitation of the results, including provisions regarding intellectual property rights. </inglise>
<eesti> 1) m&auml;&auml;rus (EM&Uuml;) nr 2821/71 annab komisjonile &otilde;iguse kohaldada asutamislepingu artikli 81 l&otilde;iget 3 (endise artikli 85 l&otilde;ige 3) m&auml;&auml;ruse andmise teel teatavat liiki kokkulepete, otsuste ja koosk&otilde;lastatud tegevuse suhtes, mis kuuluvad artikli 81 l&otilde;ike 1 kohaldamisalasse ja mille objektiks on tooteid v&otilde;i protsesse k&auml;sitlev teadus- ja arendustegevus kuni t&ouml;&ouml;stusliku rakendamise etapini ning selle tulemuste kasutamine, sealhulgas intellektuaalomandi&otilde;igusi k&auml;sitlevad s&auml;tted; </eesti>
<inglise> (2) Article 163(2) of the Treaty calls upon the Community to encourage undertakings, including small and medium-sized undertakings, in their research and technological development activities of high quality, and to support their efforts to cooperate with one another. </inglise>
<eesti> 2) asutamislepingu artikli 163 l&otilde;ige 2 kutsub &uuml;hendust &uuml;les ergutama ettev&otilde;tjaid, sealhulgas v&auml;ikesi ja keskmise suurusega ettev&otilde;tjaid, nende k&otilde;rgetasemelises teadusuuringute ja tehnoloogiaarenduse alases tegevuses ning toetama nende p&uuml;&uuml;dlusi teha &uuml;ksteisega koost&ouml;&ouml;d. </eesti>
<inglise> Pursuant to Council Decision 1999/65/EC of 22 December 1998 concerning the rules for the participation of undertakings, research centres and universities and for the dissemination of research results for the implementation of the fifth framework programme of the European Community (1998-2002) (3) and Commission Regulation (EC) No 996/1999(4) on the implementation of Decision 1999/65/EC, indirect research and technological development (RTD) actions supported under the fifth framework programme of the Community are required to be carried out cooperatively. </inglise>
<eesti> N&otilde;ukogu 22. detsembri 1998. aasta otsuse 1999/65/E&Uuml; (ettev&otilde;tjate, uurimiskeskuste ja &uuml;likoolide osalemise ning uurimistulemuste levitamise eeskirjade kohta Euroopa &Uuml;henduse viienda raamprogrammi (1998-2002) elluviimisel (3)) ning otsuse 1999/65/E&Uuml; rakendamist k&auml;sitleva komisjoni m&auml;&auml;ruse (E&Uuml;) nr 996/1999 (4) alusel peavad &uuml;henduse viienda raamprogrammi alusel toetatavad kaudsed uuringud ja tehnoloogiaarendus toimuma koost&ouml;&ouml;s; </eesti>
<inglise> (3) Agreements on the joint execution of research work or the joint development of the results of the research, up to but not including the stage of industrial application, generally do not fall within the scope of Article 81(1) of the Treaty. </inglise>
<eesti> 3) kokkulepped teadusuuringute &uuml;hiseks l&auml;biviimiseks v&otilde;i uurimistulemuste &uuml;hiseks arendamiseks kuni t&ouml;&ouml;stusliku rakendamise etapini, viimane v&auml;lja arvatud, ei kuulu &uuml;ldjuhul asutamislepingu artikli 81 l&otilde;ike 1 reguleerimisalasse. </eesti>
<inglise> In certain circumstances, however, such as where the parties agree not to carry out other research and development in the same field, thereby forgoing the opportunity of gaining competitive advantages over the other parties, such agreements may fall within Article 81(1) and should therefore be included within the scope of this Regulation. </inglise>
<eesti> Teatavatel asjaoludel, n&auml;iteks kui pooled lepivad kokku mitte korraldada muud teadus- ja arendustegevust samas valdkonnas, loobudes niiviisi v&otilde;imalusest saavutada teiste poolte ees konkurentsieelis, v&otilde;ivad sellised kokkulepped siiski kuuluda artikli 81 l&otilde;ike 1 reguleerimisalasse ja need tuleks seet&otilde;ttu l&uuml;litada k&auml;esoleva m&auml;&auml;ruse reguleerimisalasse; </eesti>
<inglise> (4) Pursuant to Regulation (EEC) No 2821/71, the Commission has, in particular, adopted Regulation (EEC) No 418/85 of 19 December 1984 on the application of Article 85(3) of the Treaty to categories of research and development agreements(5), as last amended by Regulation (EC) No 2236/97(6). Regulation (EEC) No 418/85 expires on 31 December 2000. </inglise>
<eesti> 4) m&auml;&auml;ruse (EM&Uuml;) nr 2821/71 alusel on komisjon eelk&otilde;ige vastu v&otilde;tnud 19. detsembri 1984. aasta m&auml;&auml;ruse (EM&Uuml;) nr 418/85 asutamislepingu artikli 85 l&otilde;ike 3 kohaldamise kohta teadus- ja arenduskokkulepete liikide suhtes, (5) viimati muudetud m&auml;&auml;rusega (E&Uuml;) nr 2236/97. (6) M&auml;&auml;rus (EM&Uuml;) nr 418/85 kaotab kehtivuse 31. detsembril 2000; </eesti>
<inglise> (5) A new regulation should meet the two requirements of ensuring effective protection of competition and providing adequate legal security for undertakings. </inglise>
<eesti> 5) uus m&auml;&auml;rus peaks vastama kahele n&otilde;udele, nimelt tagama konkurentsi t&otilde;husa kaitse ja andma ettev&otilde;tjatele piisava &otilde;iguskindluse. </eesti>
<inglise> The pursuit of these objectives should take account of the need to simplify administrative supervision and the legislative framework to as great an extent possible. </inglise>
<eesti> Nende eesm&auml;rkide saavutamisel tuleks arvesse v&otilde;tta vajadust v&otilde;imalikult suures ulatuses lihtsustada haldusj&auml;relevalvet ja &otilde;igusraamistikku. </eesti>
<inglise> Below a certain level of market power it can, for the application of Article 81(3), in general be presumed that the positive effects of research and development agreements will outweigh any negative effects on competition. </inglise>
<eesti> Alla turuv&otilde;imu teatava taseme v&otilde;ib artikli 81 l&otilde;ike 3 kohaldamisel &uuml;ldiselt eeldada, et teadus- ja arenduskokkulepete positiivne m&otilde;ju kaalub &uuml;les nende negatiivse m&otilde;ju konkurentsile; </eesti>
<inglise> (6) Regulation (EEC) No 2821/71 requires the exempting regulation of the Commission to define the categories of agreements, decisions and concerted practices to which it applies, to specify the restrictions or clauses which may, or may not, appear in the agreements, decisions and concerted practices, and to specify the clauses which must be contained in the agreements, decisions and concerted practices or the other conditions which must be satisfied. </inglise>
<eesti> 6) m&auml;&auml;rus (EM&Uuml;) nr 2821/71 n&otilde;uab, et erandi kehtestav komisjoni m&auml;&auml;rus m&auml;&auml;ratleks oma kohaldamisalasse kuuluvate kokkulepete, otsuste ja koosk&otilde;lastatud tegevuse liigid ning m&auml;&auml;raks kindlaks kitsendused v&otilde;i s&auml;tted, mis v&otilde;ivad v&otilde;i ei v&otilde;i neis kokkulepetes, otsustes v&otilde;i koosk&otilde;lastatud tegevuses esineda, samuti m&auml;&auml;raks kindlaks punktid, mis peavad neis kokkulepetes, otsustes ja koosk&otilde;lastatud tegevuses sisalduma, v&otilde;i muud tingimused, mis tuleb t&auml;ita; </eesti>
<inglise> (7) It is appropriate to move away from the approach of listing exempted clauses and to place greater emphasis on defining the categories of agreements which are exempted up to a certain level of market power and on specifying the restrictions or clauses which are not to be contained in such agreements. </inglise>
<eesti> 7) otstarbekas on eemalduda l&auml;henemisviisist, mille kohaselt loetletakse punktid, mille suhtes erandeid tehakse, ning asetada suuremat r&otilde;hku nende kokkuleppeliikide m&auml;&auml;ratlemisele, mille suhtes erandid kuni turuv&otilde;imu teatava tasemeni kehtivad, ning kitsenduste v&otilde;i selliste s&auml;tete kindlaksm&auml;&auml;ramisele, mis ei tohi sellistes kokkulepetes sisalduda. </eesti>
<inglise> This is consistent with an economics based approach which assesses the impact of agreements on the relevant market. </inglise>
<eesti> See on koosk&otilde;las majandusp&otilde;hise l&auml;henemisviisiga, mis hindab kokkulepete m&otilde;ju vastavale turule; </eesti>
<inglise> (8) For the application of Article 81(3) by regulation, it is not necessary to define those agreements which are capable of falling within Article 81(1). </inglise>
<eesti> 8) artikli 81 l&otilde;ike 3 kohaldamiseks m&auml;&auml;ruse andmise teel ei ole vaja m&auml;&auml;ratleda neid kokkuleppeid, mis v&otilde;ivad kuuluda artikli 81 l&otilde;ike 1 alla. </eesti>
<inglise> In the individual assessment of agreements under Article 81(1), account has to be taken of several factors, and in particular the market structure on the relevant market. </inglise>
<eesti> Artikli 81 l&otilde;ike 1 alla kuuluvate kokkulepete eraldi hindamise k&auml;igus tuleb arvesse v&otilde;tta mitmeid tegureid, eelk&otilde;ige asjaomase turu struktuuri; </eesti>
<inglise> (9) The benefit of the block exemption should be limited to those agreements for which it can be assumed with sufficient certainty that they satisfy the conditions of Article 81(3). </inglise>
<eesti> 9) grupierandist saadav kasu peaks piirduma nende kokkulepetega, mille puhul on v&otilde;imalik piisava kindlusega eeldada, et nad vastavad asutamislepingu artikli 81 l&otilde;ike 3 tingimustele; </eesti>
<inglise> (10) Cooperation in research and development and in the exploitation of the results generally promotes technical and economic progress by increasing the dissemination of know-how between the parties and avoiding duplication of research and development work, by stimulating new advances through the exchange of complementary know-how, and by rationalising the manufacture of the products or application of the processes arising out of the research and development. </inglise>
<eesti> 10) koost&ouml;&ouml; teadus- ja arendustegevuses ning tulemuste kasutamine soodustab &uuml;ldjuhul tehnika ja majanduse arengut, suurendades oskusteabe levikut osaliste seas ja v&auml;ltides kattuvat teadus- ja arendust&ouml;&ouml;d, andes t&otilde;uke uuteks edusammudeks t&auml;iendava oskusteabe vahetamise kaudu ning t&otilde;hustades teadus- ja arendust&ouml;&ouml;st tulenevate toodete valmistamist v&otilde;i protsesside rakendamist; </eesti>
<inglise> (11) The joint exploitation of results can be considered as the natural consequence of joint research and development. </inglise>
<eesti> 11) tulemuste &uuml;hist kasutamist v&otilde;ib pidada &uuml;hise teadus- ja arendustegevuse loomulikuks tagaj&auml;rjeks. </eesti>
<inglise> It can take different forms such as manufacture, the exploitation of intellectual property rights that substantially contribute to technical or economic progress, or the marketing of new products. </inglise>
<eesti> See v&otilde;ib v&otilde;tta mitmeid vorme, nagu n&auml;iteks toodete valmistamine, tehnilisele v&otilde;i majanduslikule progressile olulisel m&auml;&auml;ral kaasaaitavate intellektuaalomandi&otilde;iguste kasutamine v&otilde;i uute toodete turustamine; </eesti>
<inglise> (12) Consumers can generally be expected to benefit from the increased volume and effectiveness of research and development through the introduction of new or improved products or services or the reduction of prices brought about by new or improved processes. </inglise>
<eesti> 12) &uuml;ldjuhul v&otilde;ib eeldada, et tarbijad saavad teadus- ja arendustegevuse suurenenud mahust ja tulemuslikkusest kasu uute v&otilde;i t&auml;iustatud toodete v&otilde;i teenuste kasutuselev&otilde;tmise n&auml;ol v&otilde;i hindade langemisel uute v&otilde;i t&auml;iustatud protsesside tulemusena; </eesti>
<inglise> (13) In order to attain the benefits and objectives of joint research and development the benefit of this Regulation should also apply to provisions contained in research and development agreements which do not constitute the primary object of such agreements, but are directly related to and necessary for their implementation. </inglise>
<eesti> 13) et saavutada &uuml;hise teadus- ja arendustegevuse eeliseid ja eesm&auml;rke, peaks k&auml;esolevast m&auml;&auml;rusest tulenevad eelised laienema ka neile teadus- ja arenduskokkulepetes sisalduvatele s&auml;tetele, mis ei kujuta endast selliste kokkulepete esmast objekti, kuid on otseselt seotud nende rakendamisega ja selleks vajalikud; </eesti>
<inglise> (14) In order to justify the exemption, the joint exploitation should relate to products or processes for which the use of the results of the research and development is decisive, and each of the parties is given the opportunity of exploiting any results that interest it. </inglise>
<eesti> 14) et p&otilde;hjendada erandi &otilde;igustatust, peaks &uuml;hine kasutamine olema seotud toodete v&otilde;i protsessidega, mille puhul teadus- ja arendustegevuse tulemuste kasutamine on otsustava t&auml;htsusega, ning k&otilde;igile pooltele on antud v&otilde;imalus kasutada talle huvipakkuvaid tulemusi. </eesti>
<inglise> However, where academic bodies, research institutes or undertakings which supply research and development as a commercial service without normally being active in the exploitation of results participate in research and development, they may agree to use the results of research and development solely for the purpose of further research. </inglise>
<eesti> Kui teadus- ja uurimistegevuses osalevad akadeemilised asutused, uurimisinstituudid v&otilde;i ettev&otilde;tjad, kes pakuvad teadus- ja arendustegevust &auml;riteenusena, ilma et nad tavaliselt tegeleksid aktiivselt tulemuste kasutamisega, v&otilde;ivad nad siiski kokku leppida kasutada teadus- ja arendustegevuse tulemusi &uuml;ksnes edasise uurimist&ouml;&ouml; eesm&auml;rkidel. </eesti>
<inglise> Similarly, non-competitors may agree to limit their right to exploitation to one or more technical fields of application to facilitate cooperation between parties with complementary skills. </inglise>
<eesti> Samuti v&otilde;ivad omavahel mittekonkureerivad pooled kokkuleppeliselt piirata oma kasutus&otilde;igusi &uuml;he v&otilde;i enama tehnilise kasutusalaga, et h&otilde;lbustada vastastikku t&auml;iendavate oskustega poolte koost&ouml;&ouml;d; </eesti>
<inglise> (15) The exemption granted under this Regulation should be limited to research and development agreements which do not afford the undertakings the possibility of eliminating competition in respect of a substantial part of the products or services in question. </inglise>
<eesti> 15) k&auml;esoleva m&auml;&auml;ruse alusel tehtavad erandid peaksid piirduma teadus- ja arenduskokkulepetega, mis ei anna ettev&otilde;tjatele v&otilde;imalust k&otilde;nealuste toodete v&otilde;i teenuste olulise osa suhtes konkurentsi kaotada. </eesti>
<inglise> It is necessary to exclude from the block exemption agreements between competitors whose combined share of the market for products or services capable of being improved or replaced by the results of the research and development exceeds a certain level at the time the agreement is entered into. </inglise>
<eesti> Grupierandist on vaja v&auml;lja j&auml;tta kokkulepped konkurentide vahel, kelle &uuml;hine turuosa teadus- ja arendustegevuse tulemuste l&auml;bi t&auml;iustatavate v&otilde;i asendatavate toodete v&otilde;i teenuste turul &uuml;letab kokkuleppe s&otilde;lmimise ajal teatava taseme; </eesti>
<inglise> (16) In order to guarantee the maintenance of effective competition during joint exploitation of the results, provision should be made for the block exemption to cease to apply if the parties' combined share of the market for the products arising out of the joint research and development becomes too great. </inglise>
<eesti> 16) et tagada t&otilde;husa konkurentsi p&uuml;simine tulemuste &uuml;hise kasutamise kestel, tuleks ette n&auml;ha, et grupierand lakkab kehtimast, kui poolte &uuml;hine turuosa &uuml;hisest teadus- ja arendustegevusest saadavate toodete turul muutub liiga suureks. </eesti>
<inglise> The exemption should continue to apply, irrespective of the parties' market shares, for a certain period after the commencement of joint exploitation, so as to await stabilisation of their market shares, particularly after the introduction of an entirely new product, and to guarantee a minimum period of return on the investments involved. </inglise>
<eesti> Erandit tuleks poolte turuosast olenemata j&auml;tkuvalt kohaldada teatava aja jooksul p&auml;rast &uuml;hise kasutamise algust, et oodata &auml;ra nende turuosa stabiliseerumine, eelk&otilde;ige p&auml;rast t&auml;iesti uue toote kasutuselev&otilde;ttu, ning garanteerida asjaomaste investeeringute minimaalne tasuvusperiood; </eesti>
<inglise> (17) This Regulation should not exempt agreements containing restrictions which are not indispensable to attain the positive effects mentioned above. </inglise>
<eesti> 17) k&auml;esolev m&auml;&auml;rus ei peaks tegema erandeid kokkulepetele, mis sisaldavad kitsendusi, mis ei ole eespool nimetatud positiivse m&otilde;ju saavutamiseks h&auml;davajalikud. </eesti>
<inglise> In principle certain severe anti-competitive restraints such as limitations on the freedom of parties to carry out research and development in a field unconnected to the agreement, the fixing of prices charged to third parties, limitations on output or sales, allocation of markets or customers, and limitations on effecting passive sales for the contract products in territories reserved for other parties should be excluded from the benefit of the block exemption established by this Regulation irrespective of the market share of the undertakings concerned. </inglise>
<eesti> Olenemata asjaomaste ettev&otilde;tjate turuosast, tuleks k&auml;esoleva m&auml;&auml;rusega kehtestatud grupierandist p&otilde;him&otilde;tteliselt v&auml;lja j&auml;tta teatavat liiki ranged konkurentsivastased piirangud, nagu n&auml;iteks poolte vabaduse piiramine teha teadus- ja arendust&ouml;&ouml;d kokkuleppega mitteseonduvas valdkonnas, hindade fikseerimine kolmandate isikute jaoks, tootmis- v&otilde;i m&uuml;&uuml;gimahu piiramine, turgude v&otilde;i klientide jaotamine v&otilde;i lepinguj&auml;rgsete toodete passiivse m&uuml;&uuml;gi piiramine teistele pooltele reserveeritud territooriumidel; </eesti>
<inglise> (18) The market share limitation, the non-exemption of certain agreements, and the conditions provided for in this Regulation normally ensure that the agreements to which the block exemption applies do not enable the participating undertakings to eliminate competition in respect of a substantial part of the products or services in question. </inglise>
<eesti> 18) turuosa piirangud, erandite mittetegemine teatavate kokkulepete puhul ja k&auml;esolevas m&auml;&auml;ruses s&auml;testatud tingimused tagavad tavaliselt selle, et kokkulepped, mille suhtes kohaldatakse grupierandit, ei v&otilde;imalda osalevatel ettev&otilde;tjatel k&otilde;nealuste toodete olulise osa suhtes konkurentsi kaotada; </eesti>
<inglise> (19) In particular cases in which the agreements falling under this Regulation nevertheless have effects incompatible with Article 81(3) of the Treaty, the Commission may withdraw the benefit of the block exemption. </inglise>
<eesti> 19) teatavatel juhtudel, kui k&auml;esoleva m&auml;&auml;ruse reguleerimisalasse kuuluvate kokkulepete m&otilde;ju on asutamislepingu artikli 81 l&otilde;ikega 3 siiski vastuolus, v&otilde;ib komisjon grupierandi t&uuml;histada; </eesti>
<inglise> (20) Agreements between undertakings which are not competing manufacturers of products capable of being improved or replaced by the results of the research and development will only eliminate effective competition in research and development in exceptional circumstances. </inglise>
<eesti> 20) kokkulepped ettev&otilde;tjate vahel, kes ei ole teadus- ja arendustegevuse tulemuste l&auml;bi t&auml;iustatavate v&otilde;i asendatavate toodete konkureerivad valmistajad, kaotavad t&otilde;husa konkurentsi teadus- ja arendustegevuses &uuml;ksnes erandjuhtudel. </eesti>
<inglise> It is therefore appropriate to enable such agreements to benefit from the block exemption irrespective of market share and to address such exceptional cases by way of withdrawal of its benefit. </inglise>
<eesti> Seet&otilde;ttu on kohane v&otilde;imaldada selliste kokkulepete puhul olenemata turuosast saada kasu grupierandist ning lahendada sellised erandjuhud asjaomase erandi t&uuml;histamisega; </eesti>
<inglise> (21) As research and development agreements are often of a long-term nature, especially where the cooperation extends to the exploitation of the results, the period of validity of this Regulation should be fixed at 10 years. </inglise>
<eesti> 21) et teadus- ja arenduskokkulepped on tihti oma laadilt pikaajalised, eriti kui koost&ouml;&ouml; laieneb ka tulemuste kasutamisele, tuleks k&auml;esoleva m&auml;&auml;ruse kehtivusajaks kinnitada 10 aastat; </eesti>
<inglise> (22) This Regulation is without prejudice to the application of Article 82 of the Treaty. </inglise>
<eesti> 22) k&auml;esolev m&auml;&auml;rus ei piira asutamislepingu artikli 82 kohaldamist; </eesti>
<inglise> (23) In accordance with the principle of the primacy of Community law, no measure taken pursuant to national laws on competition should prejudice the uniform application throughout the common market of the Community competition rules or the full effect of any measures adopted in implementation of those rules, including this Regulation, </inglise>
<eesti> 23) koosk&otilde;las &uuml;henduse &otilde;iguse &uuml;limuslikkuse p&otilde;him&otilde;ttega ei tohiks &uuml;kski siseriiklike konkurentsiseaduste kohaselt v&otilde;etud meede piirata &uuml;henduse konkurentsieeskirjade &uuml;htset kohaldamist kogu &uuml;histurul ega k&otilde;nealuste eeskirjade rakendamiseks vastuv&otilde;etud meetmete, sealhulgas k&auml;esoleva m&auml;&auml;ruse t&auml;ielikku toimet, </eesti>
<inglise> HAS ADOPTED THIS REGULATION: </inglise>
<eesti> ON VASTU V&Otilde;TNUD K&Auml;ESOLEVA M&Auml;&Auml;RUSE. </eesti>
<inglise> Article 1 </inglise>
<eesti> Artikkel 1 </eesti>
<inglise> Exemption </inglise>
<eesti> Erand </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> Pursuant to Article 81(3) of the Treaty and subject to the provisions of this Regulation, it is hereby declared that Article 81(1) shall not apply to agreements entered into between two or more undertakings (hereinafter referred to as "the parties") which relate to the conditions under which those undertakings pursue: </inglise>
<eesti> Vastavalt asutamislepingu artikli 81 l&otilde;ikele 3 ja kui k&auml;esoleva m&auml;&auml;ruse s&auml;tetest ei tulene teisiti, deklareeritakse k&auml;esolevaga, et asutamislepingu artikli 81 l&otilde;iget 1 ei kohaldata j&auml;rgmiste kokkulepete suhtes, mis on s&otilde;lmitud kahe v&otilde;i enama ettev&otilde;tja (edaspidi "pooled") vahel ja k&auml;sitlevad tingimusi, mille alusel k&otilde;nealused ettev&otilde;tjad tegelevad: </eesti>
<inglise> (a) joint research and development of products or processes and joint exploitation of the results of that research and development; </inglise>
<eesti> a) &uuml;hise tooteid v&otilde;i protsesse k&auml;sitleva teadus- ja arendustegevusega ning k&otilde;nealuse teadus- ja arendustegevuse tulemuste &uuml;hise kasutamisega; </eesti>
<inglise> (b) joint exploitation of the results of research and development of products or processes jointly carried out pursuant to a prior agreement between the same parties; or </inglise>
<eesti> b) samade poolte vahel varem s&otilde;lmitud kokkuleppe alusel korraldatud ning tooteid v&otilde;i protsesse k&auml;sitleva teadus- ja arendustegevuse tulemuste &uuml;hise kasutamisega; v&otilde;i </eesti>
<inglise> (c) joint research and development of products or processes excluding joint exploitation of the results. </inglise>
<eesti> a) &uuml;hise tooteid v&otilde;i protsesse k&auml;sitleva teadus- ja arendustegevusega, v&auml;lja arvatud selle tulemuste &uuml;hine kasutamine. </eesti>
<inglise> This exemption shall apply to the extent that such agreements (hereinafter referred to as "research and development agreements") contain restrictions of competition falling within the scope of Article 81(1). </inglise>
<eesti> K&auml;esolevat erandit kohaldatakse sedav&otilde;rd, kuiv&otilde;rd sellised kokkulepped (edaspidi "teadus- ja arenduskokkulepped") sisaldavad asutamislepingu artikli 81 l&otilde;ike 1 reguleerimisalasse kuuluvaid konkurentsipiiranguid. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> The exemption provided for in paragraph 1 shall also apply to provisions contained in research and development agreements which do not constitute the primary object of such agreements, but are directly related to and necessary for their implementation, such as an obligation not to carry out, independently or together with third parties, research and development in the field to which the agreement relates or in a closely connected field during the execution of the agreement. </inglise>
<eesti> L&otilde;ikes 1 s&auml;testatud grupierand kehtib ka nende teadus- ja arenduskokkulepetes sisalduvate s&auml;tete suhtes, mis ei kujuta endast selliste kokkulepete esmast objekti, ent mis on otseselt seotud nende rakendamisega ja selleks vajalikud, n&auml;iteks kohustus mitte teha kokkuleppe t&auml;itmise ajal kokkuleppega seotud valdkonnas v&otilde;i sellele l&auml;hedases valdkonnas teadus- ja arendust&ouml;&ouml;d iseseisvalt v&otilde;i koos kolmandate isikutega. </eesti>
<inglise> The first subparagraph does, however, not apply to provisions which have the same object as the restrictions of competition enumerated in Article 5(1). </inglise>
<eesti> Esimest l&otilde;iget ei kohaldata siiski s&auml;tete suhtes, millel on sama eesm&auml;rk, nagu artikli 5 l&otilde;ikes 1 loetletud konkurentsipiirangutel. </eesti>
<inglise> Article 2 </inglise>
<eesti> Artikkel 2 </eesti>
<inglise> Definitions </inglise>
<eesti> M&otilde;isted </eesti>
<inglise> For the purposes of this Regulation: </inglise>
<eesti> K&auml;esolevas m&auml;&auml;ruses kasutatakse j&auml;rgmisi m&otilde;isteid: </eesti>
<inglise> 1. "agreement" means an agreement, a decision of an association of undertakings or a concerted practice; </inglise>
<eesti> 1) kokkulepe - kokkulepe, ettev&otilde;tjate &uuml;henduse otsus v&otilde;i koosk&otilde;lastatud tegevus; </eesti>
<inglise> 2. "participating undertakings" means undertakings party to the research and development agreement and their respective connected undertakings; </inglise>
<eesti> 2) osalevad ettev&otilde;tjad - teadus- ja arenduskokkuleppe pooleks olevad ettev&otilde;tjad ja nendega seotud ettev&otilde;tjad; </eesti>
<inglise> 3. "connected undertakings" means: </inglise>
<eesti> 3) seotud ettev&otilde;tjad: </eesti>
<inglise> (a) undertakings in which a party to the research and development agreement, directly or indirectly: </inglise>
<eesti> a) ettev&otilde;tjad, kelle puhul &uuml;hel teadus- ja arenduskokkuleppe poolel on otseselt v&otilde;i kaudselt: </eesti>
<inglise> (i) has the power to exercise more than half the voting rights, </inglise>
<eesti> i) kasutada rohkem kui pooled h&auml;&auml;ltest, </eesti>
<inglise> (ii) has the power to appoint more than half the members of the supervisory board, board of management or bodies legally representing the undertaking, or </inglise>
<eesti> ii) &otilde;igus nimetada ametisse &uuml;le poole n&otilde;ukogust, juhatusest v&otilde;i ettev&otilde;tjat seaduslikult esindava organi liikmetest v&otilde;i </eesti>
<inglise> (iii) has the right to manage the undertaking's affairs; </inglise>
<eesti> iii) &otilde;igus juhtida ettev&otilde;tja &auml;ritegevust; </eesti>
<inglise> (b) undertakings which directly or indirectly have, over a party to the research and development agreement, the rights or powers listed in (a); </inglise>
<eesti> b) ettev&otilde;tjad, kellel on &uuml;he teadus- ja arenduskokkuleppe poole suhtes otseselt v&otilde;i kaudselt punktis a loetletud &otilde;igused v&otilde;i volitused; </eesti>
<inglise> (c) undertakings in which an undertaking referred to in (b) has, directly or indirectly, the rights or powers listed in (a); </inglise>
<eesti> c) ettev&otilde;tjad, kelle suhtes m&otilde;nel punktis b osutatud ettev&otilde;tjal on otseselt v&otilde;i kaudselt punktis a loetletud &otilde;igused v&otilde;i volitused; </eesti>
<inglise> (d) undertakings in which a party to the research and development agreement together with one or more of the undertakings referred to in (a), (b) or (c), or in which two or more of the latter undertakings, jointly have the rights or powers listed in (a); </inglise>
<eesti> d) ettev&otilde;tjad, kelle suhtes teadus- ja arenduskokkuleppe poolel koos &uuml;he v&otilde;i mitme punktis a, b v&otilde;i c osutatud ettev&otilde;tjaga v&otilde;i &uuml;hel v&otilde;i mitmel k&otilde;nealustes punktides osutatud ettev&otilde;tjal &uuml;hiselt on punktis a loetletud &otilde;igused v&otilde;i volitused; </eesti>
<inglise> (e) undertakings in which the rights or the powers listed in (a) are jointly held by: </inglise>
<eesti> e) ettev&otilde;tjad, kelle puhul punktis a loetletud &otilde;igused ja volitused kuuluvad &uuml;hiselt: </eesti>
<inglise> (i) parties to the research and development agreement or their respective connected undertakings referred to in (a) to (d), or </inglise>
<eesti> i) teadus- ja arenduskokkuleppe pooltele v&otilde;i nende vastavatele punktides a-d loetletud seotud ettev&otilde;tjatele v&otilde;i </eesti>
<inglise> (ii) one or more of the parties to the research and development agreement or one or more of their connected undertakings referred to in (a) to (d) and one or more third parties; </inglise>
<eesti> ii) &uuml;hele v&otilde;i mitmele teadus- ja arenduskokkuleppe poolele v&otilde;i &uuml;hele v&otilde;i mitmele punktides a-d loetletud seotud ettev&otilde;tjale ja &uuml;hele v&otilde;i mitmele kolmandale isikule; </eesti>
<inglise> 4. "research and development" means the acquisition of know-how relating to products or processes and the carrying out of theoretical analysis, systematic study or experimentation, including experimental production, technical testing of products or processes, the establishment of the necessary facilities and the obtaining of intellectual property rights for the results; </inglise>
<eesti> 4) teadus- ja arendustegevus - toodete v&otilde;i protsessidega seotud oskusteabe omandamine ning teoreetilise anal&uuml;&uuml;si tegemine, s&uuml;stemaatiline uurimist&ouml;&ouml; v&otilde;i katsetamine, sealhulgas katseline tootmine, toodete v&otilde;i protsesside teimimine, selleks vajalike v&otilde;imaluste loomine ja tulemuste suhtes intellektuaalomandi&otilde;iguste omandamine; </eesti>
<inglise> 5. "product" means a good and/or a service, including both intermediary goods and/or services and final goods and/or services; </inglise>
<eesti> 5) toode - kaup ja/v&otilde;i teenus, sealhulgas nii vaheprodukt ja/v&otilde;i -teenus kui ka l&otilde;pp-produkt ja/v&otilde;i -teenus; </eesti>
<inglise> 6. "contract process" means a technology or process arising out of the joint research and development; </inglise>
<eesti> 6) lepinguj&auml;rgne protsess - tehnoloogia v&otilde;i protsess, mis tuleneb &uuml;hisest teadus- v&otilde;i arendustegevusest; </eesti>
<inglise> 7. "contract product" means a product arising out of the joint research and development or manufactured or provided applying the contract processes; </inglise>
<eesti> 7) lepinguj&auml;rgne toode - toode, mis tuleneb &uuml;hisest teadus- v&otilde;i arendustegevusest v&otilde;i mis on valmistatud v&otilde;i tarnitud lepinguj&auml;rgset protsessi kasutades; </eesti>
<inglise> 8. "exploitation of the results" means the production or distribution of the contract products or the application of the contract processes or the assignment or licensing of intellectual property rights or the communication of know-how required for such manufacture or application; </inglise>
<eesti> 8) tulemuste kasutamine - lepinguj&auml;rgsete toodete valmistamine v&otilde;i turustamine v&otilde;i lepinguj&auml;rgsete protsesside kasutamine v&otilde;i sellise valmistamise v&otilde;i kasutamise jaoks vajalike intellektuaalomandi&otilde;iguste loovutamine v&otilde;i litsentsimine v&otilde;i oskusteabe edastamine; </eesti>
<inglise> 9. "intellectual property rights" includes industrial property rights, copyright and neighbouring rights; </inglise>
<eesti> 9) intellektuaalomandi&otilde;igused - h&otilde;lmavad t&ouml;&ouml;stusomandi&otilde;igust, autori&otilde;igust ja sellega kaasnevaid &otilde;igusi; </eesti>
<inglise> 10. "know-how" means a package of non-patented practical information, resulting from experience and testing, which is secret, substantial and identified: in this context, "secret" means that the know-how is not generally known or easily accessible; "substantial" means that the know-how includes information which is indispensable for the manufacture of the contract products or the application of the contract processes; "identified" means that the know-how is described in a sufficiently comprehensive manner so as to make it possible to verify that it fulfils the criteria of secrecy and substantiality; </inglise>
<eesti> 10) oskusteave - patentimata praktilise teabe kogum, mis tuleneb kogemustest ja katsetustest ning mis on salajane, oluline ja m&auml;&auml;ratletud: k&otilde;nealuses kontekstis t&auml;hendab "salajane", et oskusteave ei ole &uuml;ldteada ega h&otilde;lpsasti juurdep&auml;&auml;setav; "oluline" t&auml;hendab, et oskusteave h&otilde;lmab teavet, mis on h&auml;davajalik lepinguj&auml;rgsete toodete valmistamiseks v&otilde;i lepinguj&auml;rgsete protsesside rakendamiseks; "m&auml;&auml;ratletud" t&auml;hendab, et oskusteavet tuleb kirjeldada piisavalt ulatuslikult, et oleks v&otilde;imalik kontrollida, kas see vastab salajasuse ja olulisuse kriteeriumidele; </eesti>
<inglise> 11. research and development, or exploitation of the results, are carried out "jointly" where the work involved is: </inglise>
<eesti> 11) teadus- ja arendustegevus v&otilde;i tulemuste kasutamine toimub &uuml;hiselt, kui sellega seotud t&ouml;&ouml;: </eesti>
<inglise> (a) carried out by a joint team, organisation or undertaking, </inglise>
<eesti> a) teostajaks on &uuml;hisr&uuml;hm, -organisatsioon v&otilde;i -ettev&otilde;te, </eesti>
<inglise> (b) jointly entrusted to a third party, or </inglise>
<eesti> b) usaldatakse &uuml;hiselt kolmandale isikule v&otilde;i </eesti>
<inglise> (c) allocated between the parties by way of specialisation in research, development, production or distribution; </inglise>
<eesti> c) jaotatakse poolte vahel spetsialiseerumise teel teadus- ja arendustegevuse, tootmise v&otilde;i turustamise alal; </eesti>
<inglise> 12. "competing undertaking" means an undertaking that is supplying a product capable of being improved or replaced by the contract product (an actual competitor) or an undertaking that would, on realistic grounds, undertake the necessary additional investments or other necessary switching costs so that it could supply such a product in response to a small and permanent increase in relative prices (a potential competitor); </inglise>
<eesti> 12) konkureeriv ettev&otilde;tja - ettev&otilde;tja, kes tarnib toodet, mida lepinguj&auml;rgne toode v&otilde;ib t&auml;iustada v&otilde;i asendada (tegelik konkurent), v&otilde;i ettev&otilde;tja, kel on realistlikud eeldused teha vajalikud lisainvesteeringud v&otilde;i muud vajalikud &uuml;mberl&uuml;litumiskulutused, et ta v&otilde;iks asuda tarnima sellist toodet suhteliste hindade v&auml;ikese, kuid p&uuml;siva t&otilde;usu korral (potentsiaalne konkurent); </eesti>
<inglise> 13. "relevant market for the contract products" means the relevant product and geographic market(s) to which the contract products belong. </inglise>
<eesti> 13) lepinguj&auml;rgsete toodete asjaomane turg - asjaomane tooteturg ja geograafiline turg v&otilde;i turud, kuhu lepinguj&auml;rgsed tooted kuuluvad. </eesti>
<inglise> Article 3 </inglise>
<eesti> Artikkel 3 </eesti>
<inglise> Conditions for exemption </inglise>
<eesti> Erandi tegemise tingimused </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> The exemption provided for in Article 1 shall apply subject to the conditions set out in paragraphs 2 to 5. </inglise>
<eesti> Artiklis 1 s&auml;testatud erandit kohaldatakse &uuml;ksnes l&otilde;igetes 2 ja 5 s&auml;testatud tingimuste t&auml;itmise korral. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> All the parties must have access to the results of the joint research and development for the purposes of further research or exploitation. </inglise>
<eesti> K&otilde;ikidel pooltel peab olema juurdep&auml;&auml;s &uuml;hise teadus- ja arendustegevuse tulemustele nende kasutamiseks v&otilde;i edasisteks teadusuuringuteks. </eesti>
<inglise> However, research institutes, academic bodies, or undertakings which supply research and development as a commercial service without normally being active in the exploitation of results may agree to confine their use of the results for the purposes of further research. </inglise>
<eesti> Teadus- ja uurimistegevuses osalevad akadeemilised asutused, uurimisinstituudid v&otilde;i ettev&otilde;tjad, kes pakuvad teadus- ja arendustegevust &auml;riteenusena, ilma et nad tavaliselt tegeleksid aktiivselt tulemuste kasutamisega, v&otilde;ivad siiski kokkuleppeliselt piirduda tulemuste kasutamisel &uuml;ksnes edasise uurimist&ouml;&ouml;ga. </eesti>
<inglise> 3. </inglise>
<eesti> 3. </eesti>
<inglise> Without prejudice to paragraph 2, where the research and development agreement provides only for joint research and development, each party must be free independently to exploit the results of the joint research and development and any pre-existing know-how necessary for the purposes of such exploitation. </inglise>
<eesti> Ilma et see piiraks l&otilde;ike 2 kohaldamist, peab juhul, kui teadus- ja arenduskokkulepe n&auml;eb ette &uuml;ksnes &uuml;hise teadus- ja arendustegevuse, k&otilde;igil pooltel olema vaba voli kasutada &uuml;hise teadus- ja arendustegevuse tulemusi ja kogu varem olemas olnud oskusteavet, mis on selliseks kasutamiseks vajalik. </eesti>
<inglise> Such right to exploitation may be limited to one or more technical fields of application, where the parties are not competing undertakings at the time the research and development agreement is entered into. </inglise>
<eesti> Kui pooled ei ole teadus- ja arenduskokkuleppe s&otilde;lmimise ajal omavahel konkureerivad ettev&otilde;tjad, v&otilde;ib selline kasutus&otilde;igus piirduda &uuml;he v&otilde;i mitme tehnilise kasutusalaga. </eesti>
<inglise> 4. </inglise>
<eesti> 4. </eesti>
<inglise> Any joint exploitation must relate to results which are protected by intellectual property rights or constitute know-how, which substantially contribute to technical or economic progress and the results must be decisive for the manufacture of the contract products or the application of the contract processes. </inglise>
<eesti> Mis tahes &uuml;hiskasutus peab olema seotud tulemustega, mis on kaitstud intellektuaalomandi&otilde;igustega v&otilde;i kujutavad endast oskusteavet, mis annab olulise panuse tehnilisse v&otilde;i majanduslikku progressi, ning tulemused peavad lepinguj&auml;rgsete toodete valmistamisel v&otilde;i lepinguj&auml;rgsete protsesside rakendamisel olema otsustava t&auml;htsusega. </eesti>
<inglise> 5. </inglise>
<eesti> 5. </eesti>
<inglise> Undertakings charged with manufacture by way of specialisation in production must be required to fulfil orders for supplies from all the parties, except where the research and development agreement also provides for joint distribution. </inglise>
<eesti> Ettev&otilde;tjatelt, kellele on tootmise spetsialiseerimise k&auml;igus tehtud &uuml;lesandeks toote valmistamine, n&otilde;utakse k&otilde;igi poolte tarnen&otilde;udluse t&auml;itmist, v&auml;lja arvatud juhul, kui teadus- ja arenduskokkulepe n&auml;eb ette ka &uuml;hise turustamise. </eesti>
<inglise> Article 4 </inglise>
<eesti> Artikkel 4 </eesti>
<inglise> Market share threshold and duration of exemption </inglise>
<eesti> Turuosa k&uuml;nnis ja erandi kehtivusaeg </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> Where the participating undertakings are not competing undertakings, the exemption provided for in Article 1 shall apply for the duration of the research and development. </inglise>
<eesti> Kui osalevad ettev&otilde;tjad ei ole omavahel konkureerivad, kohaldatakse artiklis 1 s&auml;testatud erandit teadus- ja arendust&ouml;&ouml; kestuse jooksul. </eesti>
<inglise> Where the results are jointly exploited, the exemption shall continue to apply for seven years from the time the contract products are first put on the market within the common market. </inglise>
<eesti> Kui tulemusi kasutatakse &uuml;hiselt, j&auml;tkatakse erandi kohaldamist veel seitsme aasta jooksul alates lepinguj&auml;rgsete toodete esmakordsest turuleviimisest &uuml;histurul. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> Where two or more of the participating undertakings are competing undertakings, the exemption provided for in Article 1 shall apply for the period referred to in paragraph 1 only if, at the time the research and development agreement is entered into, the combined market share of the participating undertakings does not exceed 25 % of the relevant market for the products capable of being improved or replaced by the contract products. </inglise>
<eesti> Kui kaks v&otilde;i enam osalevat ettev&otilde;tjat omavahel konkureerivad, kohaldatakse artiklis 1 s&auml;testatud erandit l&otilde;ikes 1 osutatud t&auml;htaja jooksul &uuml;ksnes juhul, kui teadus- ja arenduskokkuleppe s&otilde;lmimise ajal ei &uuml;leta osalevate ettev&otilde;tjate &uuml;hine turuosa 25% asjaomasest lepinguj&auml;rgsete toodetega t&auml;iustatavate v&otilde;i asendatavate toodete turust. </eesti>
<inglise> 3. </inglise>
<eesti> 3. </eesti>
<inglise> After the end of the period referred to in paragraph 1, the exemption shall continue to apply as long as the combined market share of the participating undertakings does not exceed 25 % of the relevant market for the contract products. </inglise>
<eesti> P&auml;rast l&otilde;ikes 1 osutatud t&auml;htaja m&ouml;&ouml;dumist j&auml;tkatakse erandi kohaldamist niikaua, kui osalevate ettev&otilde;tjate &uuml;hine turuosa ei &uuml;leta 25% vastavast lepinguj&auml;rgsete toodete turust. </eesti>
<inglise> Article 5 </inglise>
<eesti> Artikkel 5 </eesti>
<inglise> Agreements not covered by the exemption </inglise>
<eesti> Kokkulepped, mille suhtes erandit ei kohaldata </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> The exemption provided for in Article 1 shall not apply to research and development agreements which, directly or indirectly, in isolation or in combination with other factors under the control of the parties, have as their object: </inglise>
<eesti> Artiklis 1 s&auml;testatud erandit ei kohaldata teadus- ja arenduskokkulepete suhtes, mille eesm&auml;rgiks on otseselt v&otilde;i kaudselt, &uuml;ksikult v&otilde;i poolte kontrolli all olevate muude teguritega kombineeritult: </eesti>
<inglise> (a) the restriction of the freedom of the participating undertakings to carry out research and development independently or in cooperation with third parties in a field unconnected with that to which the research and development relates or, after its completion, in the field to which it relates or in a connected field; </inglise>
<eesti> a) piirata osalevate ettev&otilde;tjate vabadust teha iseseisvalt v&otilde;i koos kolmandate isikutega teadus- ja arendust&ouml;&ouml;d teadus- ja arenduskokkuleppega mitteseonduvas valdkonnas v&otilde;i p&auml;rast selle l&otilde;puleviimist kokkuleppej&auml;rgses v&otilde;i sellega seonduvas valdkonnas; </eesti>
<inglise> (b) the prohibition to challenge after completion of the research and development the validity of intellectual property rights which the parties hold in the common market and which are relevant to the research and development or, after the expiry of the research and development agreement, the validity of intellectual property rights which the parties hold in the common market and which protect the results of the research and development, without prejudice to the possibilty to provide for termination of the research and development agreement in the event of one of the parties challenging the validity of such intellectual property rights; </inglise>
<eesti> b) keeld vaidlustada p&auml;rast teadus- ja arendust&ouml;&ouml; l&otilde;puleviimist pooltele &uuml;histurul kuuluvate teadus- ja arendustegevusega seotud intellektuaalomandi&otilde;iguste kehtivus v&otilde;i p&auml;rast teadus- ja arenduskokkuleppe kehtivusaja l&otilde;ppu vaidlustada pooltele &uuml;histurul kuuluvate ning teadus- ja arendust&ouml;&ouml; tulemusi kaitsvate intellektuaalomandi&otilde;iguste kehtivus, ilma et seejuures piirataks v&otilde;imalust n&auml;ha ette teadus- ja arenduskokkuleppe l&otilde;petamine juhul, kui &uuml;ks pooltest selliste intellektuaalomandi&otilde;iguste kehtivuse vaidlustab; </eesti>
<inglise> (c) the limitation of output or sales; </inglise>
<eesti> c) tootmis- v&otilde;i m&uuml;&uuml;gimahu piiramine; </eesti>
<inglise> (d) the fixing of prices when selling the contract product to third parties; </inglise>
<eesti> d) hindade fikseerimine toote m&uuml;&uuml;misel kolmandatele isikutele; </eesti>
<inglise> (e) the restriction of the customers that the participating undertakings may serve, after the end of seven years from the time the contract products are first put on the market within the common market; </inglise>
<eesti> e) osalevate ettev&otilde;tjate teenindatava klientuuri kitsendamine p&auml;rast seitsme aasta m&ouml;&ouml;dumist lepinguj&auml;rgsete toodete esmakordsest turuleviimisest &uuml;histurul; </eesti>
<inglise> (f) the prohibition to make passive sales of the contract products in territories reserved for other parties; </inglise>
<eesti> f) lepinguj&auml;rgsete toodete passiivse m&uuml;&uuml;gi keeld teistele pooltele reserveeritud territooriumil; </eesti>
<inglise> (g) the prohibition to put the contract products on the market or to pursue an active sales policy for them in territories within the common market that are reserved for other parties after the end of seven years from the time the contract products are first put on the market within the common market; </inglise>
<eesti> g) keeld viia lepinguj&auml;rgseid tooteid turule v&otilde;i arendada nende aktiivse m&uuml;&uuml;gi poliitikat &uuml;histuru piiresse kuuluvatel territooriumidel, mis on reserveeritud teistele pooltele, p&auml;rast seitsme aasta m&ouml;&ouml;dumist lepinguj&auml;rgsete toodete esmakordsest turuleviimisest &uuml;histurul; </eesti>
<inglise> (h) the requirement not to grant licences to third parties to manufacture the contract products or to apply the contract processes where the exploitation by at least one of the parties of the results of the joint research and development is not provided for or does not take place; </inglise>
<eesti> h) n&otilde;ue mitte anda kolmandatele isikutele litsentse lepinguj&auml;rgsete toodete valmistamiseks v&otilde;i lepinguj&auml;rgsete protsesside kasutamiseks, kui v&auml;hemalt &uuml;hel poolel ei ole ette n&auml;htud kasutada &uuml;hise teadus- ja arendustegevuse tulemusi v&otilde;i kui sellist kasutamist ei toimu; </eesti>
<inglise> (i) the requirement to refuse to meet demand from users or resellers in their respective territories who would market the contract products in other territories within the common market; or </inglise>
<eesti> i) n&otilde;ue keelduda rahuldamast selliste kasutajate v&otilde;i edasim&uuml;&uuml;jate n&otilde;udlust nende vastaval territooriumil, kes turustaksid lepinguj&auml;rgseid tooteid muudel &uuml;histuru piiresse j&auml;&auml;vatel territooriumidel; v&otilde;i </eesti>
<inglise> (j) the requirement to make it difficult for users or resellers to obtain the contract products from other resellers within the common market, and in particular to exercise intellectual property rights or take measures so as to prevent users or resellers from obtaining, or from putting on the market within the common market, products which have been lawfully put on the market within the Community by another party or with its consent. </inglise>
<eesti> j) n&otilde;ue raskendada kasutajatel ja edasim&uuml;&uuml;jatel lepinguj&auml;rgsete toodete saamist muudelt edasim&uuml;&uuml;jatelt &uuml;histuru piires ning eelk&otilde;ige raskendada intellektuaalomandi&otilde;iguste teostamist ning v&otilde;tta meetmeid, et takistada kasutajatel v&otilde;i edasim&uuml;&uuml;jatel selliste toodete hankimist v&otilde;i turuleviimist &uuml;histurul, mis on &uuml;henduse piires seaduslikult turule viidud muu isiku poolt v&otilde;i n&otilde;usolekul. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> Paragraph 1 shall not apply to: </inglise>
<eesti> L&otilde;iget 1 ei kohaldata: </eesti>
<inglise> (a) the setting of production targets where the exploitation of the results includes the joint production of the contract products; </inglise>
<eesti> a) tootmissihtide seadmisel, kui tulemuste kasutamine h&otilde;lmab lepinguj&auml;rgsete toodete &uuml;histootmist; </eesti>
<inglise> (b) the setting of sales targets and the fixing of prices charged to immediate customers where the exploitation of the results includes the joint distribution of the contract products. </inglise>
<eesti> b) m&uuml;&uuml;giplaanide seadmisel ja hindade fikseerimisel vahetute klientide jaoks, kui tulemuste kasutamine h&otilde;lmab lepinguj&auml;rgsete toodete &uuml;hist turustamist. </eesti>
<inglise> Article 6 </inglise>
<eesti> Artikkel 6 </eesti>
<inglise> Application of the market share threshold </inglise>
<eesti> Turuosa k&uuml;nnise kohaldamine </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> For the purposes of applying the market share threshold provided for in Article 4 the following rules shall apply: </inglise>
<eesti> Artiklis 4 s&auml;testatud turuosa k&uuml;nnise kohaldamisel j&auml;rgitakse j&auml;rgmisi eeskirju: </eesti>
<inglise> (a) the market share shall be calculated on the basis of the market sales value; if market sales value data are not available, estimates based on other reliable market information, including market sales volumes, may be used to establish the market share of the undertaking concerned; </inglise>
<eesti> a) turuosa arvutamise aluseks v&otilde;etakse m&uuml;&uuml;giv&auml;&auml;rtus turul; kui andmed m&uuml;&uuml;giv&auml;&auml;rtuse kohta turul ei ole k&auml;ttesaadavad, v&otilde;ib asjaomase ettev&otilde;tja turuosa kindlaksm&auml;&auml;ramiseks kasutada hinnanguid, mis p&otilde;hinevad muudel usaldusv&auml;&auml;rsetel turgu k&auml;sitlevatel andmetel, sealhulgas turu m&uuml;&uuml;gimahul; </eesti>
<inglise> (b) the market share shall be calculated on the basis of data relating to the preceding calendar year; </inglise>
<eesti> b) turuosa arvutatakse eelnevat kalendriaastat k&auml;sitlevate andmete p&otilde;hjal; </eesti>
<inglise> (c) the market share held by the undertakings referred to in point 3(e) of Article 2 shall be apportioned equally to each undertaking having the rights or the powers listed in point 3(a) of Article 2. </inglise>
<eesti> c) artikli 2 l&otilde;ike 3 punktis e osutatud ettev&otilde;tjatele kuuluv turuosa jagatakse v&otilde;rdselt k&otilde;igi ettev&otilde;tjate vahel, kellel on artikli 2 l&otilde;ike 3 punktis a loetletud volitused v&otilde;i &otilde;igused. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> If the market share referred to in Article 4(3) is initially not more than 25 % but subsequently rises above this level without exceeding 30 %, the exemption provided for in Article 1 shall continue to apply for a period of two consecutive calendar years following the year in which the 25 % threshold was first exceeded. </inglise>
<eesti> Kui artikli 4 l&otilde;ikes 3 osutatud turuosa esialgu ei &uuml;leta 25%, kuid t&otilde;useb hiljem nimetatud piirist k&otilde;rgemale, &uuml;letamata siiski 30% piiri, kehtib artiklis 1 s&auml;testatud erand kahe j&auml;rjestikuse kalendriaasta jooksul p&auml;rast aastat, mil turuosa 25% k&uuml;nnis esimest korda &uuml;letati. </eesti>
<inglise> 3. </inglise>
<eesti> 3. </eesti>
<inglise> If the market share referred to in Article 4(3) is initially not more than 25 % but subsequently rises above 30 %, the exemption provided for in Article 1 shall continue to apply for one calendar year following the year in which the level of 30 % was first exceeded. </inglise>
<eesti> Kui artikli 4 l&otilde;ikes 3 osutatud turuosa esialgu ei &uuml;leta 25%, kuid t&otilde;useb hiljem &uuml;le 30%, kehtib artiklis 1 s&auml;testatud erand &uuml;he kalendriaasta jooksul p&auml;rast aastat, mil turuosa 30% k&uuml;nnis esimest korda &uuml;letati. </eesti>
<inglise> 4. </inglise>
<eesti> 4. </eesti>
<inglise> The benefit of paragraphs 2 and 3 may not be combined so as to exceed a period of two calendar years. </inglise>
<eesti> L&otilde;igetes 2 ja 3 s&auml;testatud soodustusi ei v&otilde;i kombineerida selliselt, et nad &uuml;letavad kahe kalendriaasta pikkuse ajavahemiku. </eesti>
<inglise> Article 7 </inglise>
<eesti> Artikkel 7 </eesti>
<inglise> Withdrawal </inglise>
<eesti> Lepingust taganemine </eesti>
<inglise> The Commission may withdraw the benefit of this Regulation, pursuant to Article 7 of Regulation (EEC) No 2821/71, where, either on its own initiative or at the request of a Member State or of a natural or legal person claiming a legitimate interest, it finds in a particular case that a research and development agreement to which the exemption provided for in Article 1 applies nevertheless has effects which are incompatible with the conditions laid down in Article 81(3) of the Treaty, and in particular where: </inglise>
<eesti> Komisjon v&otilde;ib t&uuml;histada k&auml;esoleva m&auml;&auml;ruse kohaselt antud soodustused m&auml;&auml;ruse (EM&Uuml;) nr 2821/71 artikli 7 alusel, kui ta kas omal algatusel v&otilde;i liikmesriigi v&otilde;i oma &otilde;igustatud huvi kaitsvate f&uuml;&uuml;siliste v&otilde;i juriidiliste isikute n&otilde;udmisel leiab, et m&otilde;nel konkreetsel juhul toovad artiklis 1 s&auml;testatud erandit kasutavad teadus- ja arenduskokkulepped siiski kaasa asutamislepingu artikli 81 l&otilde;ikes 3 s&auml;testatud tingimustega kokkusobimatuid tagaj&auml;rgi, eelk&otilde;ige juhul, kui: </eesti>
<inglise> (a) the existence of the research and development agreement substantially restricts the scope for third parties to carry out research and development in the relevant field because of the limited research capacity available elsewhere; </inglise>
<eesti> a) teadus- ja arenduskokkuleppe olemasolu kitsendab olulisel m&auml;&auml;ral kolmandate isikute v&otilde;imalust teha asjaomases valdkonnas teadus- ja arendust&ouml;&ouml;d, sest mujal k&auml;ttesaadavad uurimist&ouml;&ouml;v&otilde;imalused on piiratud; </eesti>
<inglise> (b) because of the particular structure of supply, the existence of the research and development agreement substantially restricts the access of third parties to the market for the contract products; </inglise>
<eesti> b) teadus- ja arenduskokkulepe kitsendab tarnete erilise struktuuri t&otilde;ttu olulisel m&auml;&auml;ral kolmandate isikute juurdep&auml;&auml;su lepinguj&auml;rgsete toodete turule; </eesti>
<inglise> (c) without any objectively valid reason, the parties do not exploit the results of the joint research and development; </inglise>
<eesti> c) pooled j&auml;tavad &uuml;hise teadus- ja arendustegevuse tulemused ilma objektiivse p&otilde;hjuseta kasutamata; </eesti>
<inglise> (d) the contract products are not subject in the whole or a substantial part of the common market to effective competition from identical products or products considered by users as equivalent in view of their characteristics, price and intended use; </inglise>
<eesti> d) lepinguj&auml;rgsetel toodetel puudub &uuml;histurul v&otilde;i selle olulises osas t&otilde;hus konkurents samalaadsete kaupadega v&otilde;i kaupadega, mida tarbijad peavad omadustelt, hinnalt ja otstarbelt v&otilde;rdv&auml;&auml;rseks; </eesti>
<inglise> (e) the existence of the research and development agreement would eliminate effective competition in research and development on a particular market. </inglise>
<eesti> e) teadus- ja arenduskokkuleppe olemasolu kaotaks teadus- ja arendustegevuse alase t&otilde;husa konkurentsi asjaomasel turul. </eesti>
<inglise> Article 8 </inglise>
<eesti> Artikkel 8 </eesti>
<inglise> Transitional period </inglise>
<eesti> &Uuml;leminekuperiood </eesti>
<inglise> The prohibition laid down in Article 81(1) of the Treaty shall not apply during the period from 1 January 2001 to 30 June 2002 in respect of agreements already in force on 31 December 2000 which do not satisfy the conditions for exemption provided for in this Regulation but which satisfy the conditions for exemption provided for in Regulation (EEC) No 418/85. </inglise>
<eesti> E&Uuml; asutamislepingu artikli 81 l&otilde;ikes 1 s&auml;testatud keeldu ei kohaldata ajavahemikus 1. jaanuarist 2001 kuni 30. juunini 2002 nende kokkulepete suhtes, mis on 31. detsembril 2000 juba j&otilde;us ja mis ei vasta k&auml;esolevas m&auml;&auml;ruses s&auml;testatud erandi tingimustele, kuid vastavad m&auml;&auml;ruses (EM&Uuml;) nr 418/85 s&auml;testatud erandi tingimustele. </eesti>
<inglise> Article 9 </inglise>
<eesti> Artikkel 9 </eesti>
<inglise> Period of validity </inglise>
<eesti> Kehtivusaeg </eesti>
<inglise> This Regulation shall enter into force on 1 January 2001. </inglise>
<eesti> K&auml;esolev m&auml;&auml;rus j&otilde;ustub 1. jaanuaril 2001. </eesti>
<inglise> It shall expire on 31 December 2010. </inglise>
<eesti> K&auml;esolev m&auml;&auml;rus aegub 31. detsembril 2010. </eesti>
<inglise> This Regulation shall be binding in its entirety and directly applicable in all Member States. </inglise>
<eesti> K&auml;esolev m&auml;&auml;rus on tervikuna siduv ja vahetult kohaldatav k&otilde;ikides liikmesriikides. </eesti>
<inglise> Done at Brussels, 29 November 2000. </inglise>
<eesti> Br&uuml;ssel, 29. november 2000 </eesti>
<inglise> For the Commission Mario Monti Member of the Commission </inglise>
<eesti> Komisjoni nimel komisjoni liige Mario Monti </eesti>
<inglise> (1) OJ L 285, 29.12.1971, p. 46. </inglise>
<eesti> (1) E&Uuml;T L 285, 29.12.1971, lk 46. </eesti>
<inglise> (2) OJ C 118, 27.4.2000, p. 3. </inglise>
<eesti> (2) E&Uuml;T C 118, 27.04.2000, lk 3. </eesti>
<inglise> (3) OJ L 26, 1.2.1999, p. 46. </inglise>
<eesti> (3) E&Uuml;T L 26, 1.02.1999, lk 46. </eesti>
<inglise> (4) OJ L 122, 12.5.1999, p. 9. </inglise>
<eesti> (4) E&Uuml;T L 122, 12.05.1999, lk 9. </eesti>
<inglise> (5) OJ L 53, 22.2.1985, p. 5. </inglise>
<eesti> (5) E&Uuml;T L 53, 22.02.1985, lk 5. </eesti>
<inglise> (6) OJ L 306, 11.11.1997, p. 12. </inglise>
<eesti> (6) E&Uuml;T L 306, 11.11.1997, lk 12. </eesti>
 